Why the study?
Cardiovascular risk factors causing endothelial dysfunction and left ventricular diastolic dysfunction increase heart failure risk, prompting investigation into their relationship with SCORE2-assessed cardiovascular risk and heart failure.
How do plasma ADMA and NT-proBNP concentrations relate to left ventricular diastolic dysfunction severity, SCORE2 cardiovascular risk, and heart failure in middle-aged adults undergoing cardiology evaluation?
Cross-Sectional (n=178)
Yes
How do plasma ADMA and NT-proBNP concentrations relate to left ventricular diastolic dysfunction severity, SCORE2 cardiovascular risk, and heart failure in middle-aged adults undergoing cardiology evaluation?
While LVDD severity positively correlates with SCORE2 risk, heart failure, and NT-proBNP, plasma ADMA is paradoxically lowest in severe LVDD due to the ADMA-lowering effects of cardiovascular polytherapy and statins.
Background: Cardiovascular (CV) risk factors, causing endothelial dysfunction (ED) and left ventricular diastolic dysfunction (LVDD), contribute to an increased risk of heart failure (HF). The aim of this study was to determine the relationship between the occurrence of LVDD and ED with CV risk assessed by the Systematic Coronary Risk Evaluation2 (SCORE2) algorithm and HF. Methods: In the period from November 2019 to May 2022, a cross-sectional study that included 178 middle-aged adults was conducted. Transthoracic echocardiography (TTE) was used to assess left ventricular (LV) diastolic and systolic function. ED was assessed using the plasma values of asymmetric dimethylarginine (ADMA) and was determined using the ELISA method. Results: The majority of subjects with LVDD grades 2 and 3 had high/very high SCORE2, developed HF and all were taking medication (p < 0.001). They also had significantly lowest plasma ADMA values (p < 0.001). We found that the reduction of ADMA concentration is influenced by certain groups of drugs, or more significantly, by their combinations (p < 0.001). Conclusions: In our study, we confirmed a positive correlation between LVDD, HF and SCORE2 severity. The results showed a negative correlation between the biomarkers of ED, LVDD severity, HF, and SCORE2, which we believe is due to medication effects.
No takes yet. Share an insight, caveat, or question.
Sušić et al. (2023) conducted a cross-sectional in Left ventricular diastolic dysfunction (LVDD) and heart failure (HF) (n=178). Plasma asymmetric dimethylarginine (ADMA) and NT-proBNP levels across LVDD grades and cardiovascular pharmacotherapy vs. Normal left ventricular diastolic function (LVDF) or monotherapy/no therapy was evaluated on Association of LVDD severity (grades 2 and 3) with SCORE2 risk, heart failure prevalence, and plasma ADMA and NT-proBNP concentrations (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: